
Telbid Trio 40mg/5mg/12.5mg Tablet
Marketer
Eswar Therapeutics Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telbid Trio 40mg/5mg/12.5mg Tablet
Triomix 40/5/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation effectively lowers elevated blood pressure, mitigating the risk of stroke and heart attack. Triomix 40/5/12.5mg may be taken with or without food; dosage is individualized and should be consistently administered at the same time daily. Continuous use, as directed by your physician, is crucial; discontinuation increases cardiovascular event risk. As it includes a diuretic, avoiding late-evening administration is recommended to minimize nighttime urination. Regular use maximizes therapeutic benefit, even during asymptomatic periods. Common side effects encompass headache, dizziness, lassitude, altered taste, fatigue, influenza-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counter potential dehydration symptoms. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medications, particularly those for cardiovascular issues. Regular monitoring of blood pressure, renal function, electrolyte levels, and glucose is essential to ensure treatment efficacy.
Primary Ingredients of Telbid Trio 40mg/5mg/12.5mg Tablet
No information provided. Therefore, no rephrased text can be given.
Uses of Telbid Trio 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telbid Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telbid Trio 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Telbid Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telbid Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Telbid Trio 40mg/5mg/12.5mg tablet should be swallowed whole; do not break, crush, or chew it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Telbid Trio 40mg/5mg/12.5mg Tablet works:
Each Telbid Trio 40mg/5mg/12.5mg tablet unites telmisartan, amlodipine, and hydrochlorothiazide to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act by vasodilation, reducing vascular resistance and consequently blood pressure. Hydrochlorothiazide, a diuretic, facilitates fluid excretion, lowering blood volume and further promoting vasodilation for improved circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telbid Trio 40mg/5mg/12.5mg tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Telbid Trio 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
The combination medication Telbid Trio (40mg/5mg/12.5mg) tablets is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this drug.
DrivingUNSAFE
Driving ability may be impaired by Telbid Trio 40mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headaches, nausea, or fatigue. These side effects can reduce concentration and thus impact safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telbid Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Telbid Trio 40mg/5mg/12.5mg tablets are generally not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Telbid Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Telbid Trio 40mg/5mg/12.5mg Tablet :
Should you forget to take a Telbid Trio 40mg/5mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telbid Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Heart |
